Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer-Reference-Cited by-同舟云学术

Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer

Published:2017-08-19 Issue: Volume:120 Page:35-42
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Ong Wee Loon¹²,Foroudi Farshad¹,Evans Sue²,Millar Jeremy³⁴

Affiliation:

1. Department of Radiation Oncology; Olivia Newton-John Cancer and Wellness Centre, Austin Health; Heidelberg Vic. Australia

2. Department of Epidemiology and Preventive Medicine; Monash University; Melbourne Vic. Australia

3. Alfred Health Radiation Oncology Services; Prahran Vic. Australia

4. Central Clinical School; Monash University; Melbourne Vic. Australia

Funder

Cancer Australia Priority-driven Collaborative Cancer Research Scheme

Department of Health Victoria State Government

Movember Foundation

Monash Partners Academic Health Science Research Fellowship

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13969/fullpdf

Reference34 articles.

1. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma-long-term results of phase III RTOG 85-31;Pilepich;Int J Radiat Oncol Biol Phys,2005

2. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study;Bolla;Lancet Oncol,2010

3. Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial;Denham;Lancet Oncol,2011

4. Radiotherapy and short-term androgen deprivation for localized prostate cancer;Jones;N Engl J Med,2011

5. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial;D'Amico;JAMA,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutrition services during prostate cancer androgen deprivation therapy;BMJ Supportive & Palliative Care;2023-07-04

2. Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: analysis of registry data;BMC Cancer;2022-06-07

3. Prostate cancer survival in South West Victoria;Australian Journal of Rural Health;2022-05-23

4. Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study;European Urology Focus;2021-03

5. Circulating oestrogen receptor mutations and splice variants in advanced prostate cancer;BJU International;2019-10-03